Co-opting regulation bypass repair as a gene correction strategy for monogenic disease
AbstractWith the development of CRISPR/Cas9-mediated gene editing technologies, correction of diseasecausing mutations has become possible. However, current gene correction strategies preclude mutationrepair in post-mitotic cells